ALEXIS BOSCHI: Open Payments
NPI 1447844790 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 30 payments from 8 companies in 2025. Trend: 2023 $684 · 2024 $0 · 2025 $1,050
Food & beverage: $1,050
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $295 |
| Galderma Laboratories, L.P. | 7 | $281 |
| Amgen Inc. | 5 | $135 |
| GENZYME CORPORATION | 4 | $109 |
| LEO Pharma Inc. | 2 | $102 |
| ABBVIE INC. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Organon LLC | 3 | $26 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, ANZUPGO, OTEZLA, SKYRIZI, Rhapsido, ADBRY.
Industry payments across AZ — which companies pay providers there.
